GERSTEIN; Hertzel

Patent Applications and Registrations

Patent applications and USPTO patent grants for GERSTEIN; Hertzel.The latest application filed is for "growth differentiation factor 15 as biomarker for metformin".

Company Profile

2.6.20

GERSTEIN; Hertzel - Toronto CA
GERSTEIN; Hertzel - Hamilton Ontario

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Growth Differentiation Factor 15 as Biomarker for Metformin App 20210254156 - HESS; Sibylle ; et al.	2021-08-19
Growth differentiation factor 15 as biomarker for metformin Grant 10,975,434 - Hess , et al. April 13, 2	2021-04-13
Growth Differentiation Factor 15 as Biomarker for Metformin App 20190002977 - HESS; Sibylle ; et al.	2019-01-03
New Markers For The Assessment Of The Risk For Development Of A Cardiovascular Disorder App 20170138961 - HESS; Sybille ; et al.	2017-05-18
New Markers For The Assessment Of An Increased Risk For Mortality App 20170102396 - HESS; Sybille ; et al.	2017-04-13
Basal Insulin Therapy App 20150065421 - Johnston; Peter ; et al.	2015-03-05
Method for reducing cardiovascular morbidity and mortality in prediaetic patients and patients with type 2 diabetes Grant 8,809,270 - Rosskamp , et al. August 19, 2	2014-08-19
Pharmaceutical Formulations And Use Thereof In The Prevention Of Stroke, Diabetes And/or Congestive Heart Failure App 20130317047 - SCHOLKENS; Bernward ; et al.	2013-11-28
Method For Reducing Cardiovascular Morbidity And Mortality In Prediaetic Patients And Patients With Type 2 Diabetes App 20130012433 - ROSSKAMP; Ralf ; et al.	2013-01-10
Method For Reducing Cardiovascular Morbidity And Mortality In Prediabetic Patients And Patients With Type 2 Diabetes App 20110281793 - Rosskamp; Ralf ; et al.	2011-11-17
Pharmaceutical Formulations And Use Thereof In The Prevention Of Stroke, Diabetes And/or Congestive Heart Failure App 20110263619 - Scholkens; Bernward ; et al.	2011-10-27
Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes Grant 7,977,310 - Rosskamp , et al. July 12, 2	2011-07-12
Pharmaceutical Formulations And Use Thereof In The Prevention Of Stroke, Diabetes And/or Congestive Heart Failure App 20100267798 - SCHOLKENS; Bernward ; et al.	2010-10-21
Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failure App 20090258919 - Scholkens; Bernward ; et al.	2009-10-15
Method For Reducing Cardiovascular Morbidity And Mortality In Prediabetic Patients And Patients With Type 2 Diabetes App 20080287343 - ROSSKAMP; Ralf ; et al.	2008-11-20
Use Of Inhibitors Of The Renin-angiotensin System In The Prevention Of Cardiovascular Events App 20080287403 - Scholkens; Bernward ; et al.	2008-11-20
Methods Of Lowering Glucose Levels App 20080188538 - GERSTEIN; Hertzel ; et al.	2008-08-07
Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes Grant 7,405,196 - Rosskamp , et al. July 29, 2	2008-07-29
Pharmaceutical Formulations And Use Thereof In The Prevention Of Stroke, Diabetes And/or Congestive Heart Failure App 20080125472 - Scholkens; Bernward ; et al.	2008-05-29
Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events Grant 7,368,469 - Scholkens , et al. May 6, 2	2008-05-06
Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events App 20070021491 - Scholkens; Bernward ; et al.	2007-01-25
Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and /or congestive heart failure App 20060194868 - Scholkens; Bernward ; et al.	2006-08-31
Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events App 20050101658 - Scholkens, Bernward ; et al.	2005-05-12
Method for reducing cardiovascular morbidity and martality in prediabetic patients and patients with type 2 diabetes App 20040229774 - Rosskamp, Ralf ; et al.	2004-11-18
Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events App 20040087645 - Scholkens, Bernward ; et al.	2004-05-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.